46.46.Z - Wholesale of pharmaceutical goods
10.86.Z - Manufacture of homogenised food preparations and dietetic food
10.89.Z - Manufacture of other food products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.18.Z - Agents specialised in the sale of other particular products
46.19.Z - Agents involved in the sale of a variety of goods
46.45.Z - Wholesale of perfume and cosmetics
46.75.Z - Wholesale of chemical products
72.19.Z - Other research and experimental development on natural sciences and engineering
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0 | 1 | 1,3 | 26,5 |
Gross profit (loss) | 0 | 1,1 | 1,8 | 63,5 |
EBITDA | 0 | 1,2 | 1,9 | 55,7 |
Short time liabilities | 1,4 | 3,7 | 3,7 | -0,5 |
Other operating costs | 0 | 0 | 0,3 | 637,5 |
Equity capital | 2,1 | 1,4 | 3,1 | 129,9 |
Operating profit (EBIT) | 0 | 1,2 | 1,9 | 58,8 |
Assets | 4,1 | 5,7 | 6,8 | 18,4 |
Net profit (loss) | 0 | 0,9 | 1,8 | 102,9 |
Cash | 0,5 | 1,4 | 0,4 | -73,9 |
Liabilities and provisions for liabilities | 2 | 4,4 | 3,7 | -16,1 |
Net income from sale | 2,7 | 11,6 | 15 | 29,3 |
Working assets | 3,8 | 5,5 | 6,7 | 21,9 |
Other income costs | 0 | 0,2 | 0,9 | 315,9 |
Depreciation | 0 | 0 | 0 | -28,3 |
% | % | % | p.p. | |
Profitability of capital | 0,1 | 64 | 56,5 | -7,5 |
Equity capital to total assets | 51,1 | 23,6 | 45,9 | 22,3 |
Gross profit margin | 0,1 | 9,3 | 11,7 | 2,4 |
EBITDA Margin | 0,4 | 10,8 | 13 | 2,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 194 | 115 | 89 | -26 |
Current financial liquidity indicator | 2.7068464756011963 | 1.4973371028900146 | 1.8344061374664307 | 0,3 |
Net dept to EBITDA | 74.35106658935547 | 0.6191794276237488 | 1.158128261566162 | 0,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane